• PALIVIZUMAB CHEMBL1201586 FDA Approved

    Alternate Names:

    Palivizumab
    MEDI-493
    Synagis Abbosynagis
    Synagis
    188039-54-5
    anti-RSV
    DB00110
    47205815
    DCL000829
    GTP-010

    Drug Info:

    Drug Categories therapeutic uses
    Drug Categories specific immunoglobulins
    Drug Categories serum globulins
    Drug Categories proteins
    Drug Categories pharmacologic actions
    Drug Categories immunoproteins
    Drug Categories immunoglobulins
    Drug Categories immune sera and immunoglobulins
    Drug Categories globulins
    Drug Categories chemical actions and uses
    Drug Categories blood proteins
    Drug Categories antiviral agents
    Drug Categories antiinfectives for systemic use
    Drug Categories antibodies, monoclonal, humanized
    Drug Categories antibodies, monoclonal
    Drug Categories antibodies
    Drug Categories anti-infective agents
    Drug Categories amino acids, peptides, and proteins
    Drug Groups investigational
    Drug Groups approved
    Drug Type biotech
    FDA Approval not approved
    Drug Class protein
    Drug Indications for treatment of irritable bowel syndrome
    (0 More Sources)